Aging : How Aging Works, How We Reverse Aging, and Prospects for Curing Aging Diseases

Michael Fossel

ISBN 10: 0443155003 / ISBN 13: 9780443155000

Published by Elsevier Science Publishing Co Inc Mär 2024, 2024

About this Item

Neuware - Aging: How Aging Works, How We Reverse Aging, and Prospects for Curing Aging Diseases explains the process of aging beyond mere entropy, exposing it as a complicated and dynamic process that undercuts maintenance and permits age-related disease. With a deeper understanding of the aging process, intervention becomes both easy to understand and clinically feasible. With a solid academic approach, this proposed book builds upon the substantial work published over the past 20 years, citing the newest data, up-to-date models based upon that data, and the implications for improved clinical intervention, including recent developments in gene and cell therapy. Coverage of age-related diseases includes neurodegenerative, cardiovascular, bone and joint, immune system, renal, pulmonary, and skin aging. Future directions of the field focus on interventions, including a summary of previous attempts to intervene in aging and age-related disease, the status of current research, and proposed biotech interventions, as well as their potential obstacles, risks, and benefits. This is the perfect reference for scientists, clinicians, and researchers interested in the translational research opportunities such as drug discovery, pharmacogenetics, and experimental therapeutics, not only summarizing where the field stands, but giving a clear and cogent view of where clinical medicine is going in the next decade. Seller Inventory # 9780443155000

Bibliographic Details

Title: Aging : How Aging Works, How We Reverse ...

Publisher: Elsevier Science Publishing Co Inc Mär 2024

Publication Date: 2024

Binding: Taschenbuch

Condition: Neu

About this title

Synopsis:

Aging: How Aging Works, How We Reverse Aging, and Prospects for Curing Aging Diseases explains the process of aging beyond mere entropy, exposing it as a complicated and dynamic process that undercuts maintenance and permits age-related disease. With a deeper understanding of the aging process, intervention becomes both easy to understand and clinically feasible.

With a solid academic approach, this proposed book builds upon the substantial work published over the past 20 years, citing the newest data, up-to-date models based upon that data, and the implications for improved clinical intervention, including recent developments in gene and cell therapy. Coverage of age-related diseases includes neurodegenerative, cardiovascular, bone and joint, immune system, renal, pulmonary, and skin aging. Future directions of the field focus on interventions, including a summary of previous attempts to intervene in aging and age-related disease, the status of current research, and proposed biotech interventions, as well as their potential obstacles, risks, and benefits.

This is the perfect reference for scientists, clinicians, and researchers interested in the translational research opportunities such as drug discovery, pharmacogenetics, and experimental therapeutics, not only summarizing where the field stands, but giving a clear and cogent view of where clinical medicine is going in the next decade.

• Provides a sophisticated, accurate, and clear explanation of aging
• Gives a clear explanation of the fundamental role of cell aging in age-related disease
• Offers a unified model for the role of epigenetic and telomere changes in cell aging
• Outlines effective approaches to intervention in the fundamental aging process
• Introduces upcoming interventions intended to both cure and prevent age-related diseases

About the Author:

Dr. Fossel has an MD and a PhD in neurobiology from Stanford University where he taught neurobiology and research methods. A clinical professor of medicine, he is considered to be the world foremost expert on telomeres, aging, and age-related disease. He gave the first talk at the NIH on reversal of human aging, published the first articles on the potential of telomeres as a clinical intervention, and authored the first and only medical textbook in this field. He was editor-in-chief of Rejuvenation Research and the director of the American Aging Association, and as well as the current Editor-in-Chief OBM Geriatrics. He has authored more than 100 books, chapters, and articles, including The Telomerase Revolution, which the Wall Street Journal praised as one of the best science books of the year. He is the president of Telocyte, a biotech firm taking telomere therapy to FDA human trials. He has fulfilled numerous invitations to chair academic conferences and give opening keynotes.